Hooman Kamel News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Hooman kamel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Hooman Kamel Today - Breaking & Trending Today

Apixaban for Cryptogenic Stroke With Atrial Cardiopathy

In patients with cryptogenic stroke and evidence of atrial cardiopathy without atrial fibrillation, apixaban did not reduce recurrent stroke vs aspirin in the ARCADIA trial. ....

San Francisco , United States , New York , Gregorym Marcus , Bruce Ovbiagele , Hooman Kamel , University Of California , Weill Cornell Medicine , New York City , Stroke Cerebrovascular Accident Cva , Acetylsalicylic Acid , Intracranial Hemorrhage , Ntracranial Bleeding Intracranial Haemorrhage , Recurrent Stroke , Atrial Fibrillation Af , A Fib , Atrial Fib , Trial Fibrillation Af , Trial Fibrillationa Fib , F Atrial Fibrillation ,

ASA: No Drop in Recurrent Stroke Seen With Apixaban After Cryptogenic Stroke

For patients with recent cryptogenic stroke and evidence of atrial cardiopathy, the risk for recurrent stroke is not reduced with apixaban. ....

New York , United States , Hooman Kamel , American Stroke Association International Conference , Journal Of The American Medical Association , Healthday News , American Medical Association , Weill Cornell Medicine , New York City , Pfizer Alliance , Roche Diagnostics ,

ASA: No Drop in Recurrent Stroke Seen With Apixaban After Cryptogenic Stroke

No significant difference noted in recurrent stroke, symptomatic intracranial hemorrhage for patients receiving apixaban, aspirin. ....

United States , New York , Hooman Kamel , Journal Of The American Medical Association , American Stroke Association International Conference , Healthday News , American Medical Association , Weill Cornell Medicine , New York City , Pfizer Alliance , Roche Diagnostics ,

Apixaban no better than aspirin for preventing some strokes

A multicenter, phase 3 clinical trial has found that apixaban is no more effective than aspirin at preventing a second stroke in patients diagnosed with a milder, related condition called atrial cardiopathy, according to new research. ....

United States , Hooman Kamel , Mitchell Elkind , Presbyterian Columbia University Irving Medical Center , Columbia University Vagelos College Of Physicians , Department Of Neurology , Presbyterian Weill Cornell Medical Center , American Heart Association , Research Institute At Weill Cornell Medicine , Weill Cornell Medicine , Columbia University Vagelos College , Albert Moon Professor , Translational Neuroscience Unit , Feil Family Brain , Mind Research Institute , Weill Cornell Medical , Columbia University Irving Medical , American Heart , Atrial Cardiopathy ,

Apixaban Matches Aspirin in Preventing Certain Strokes

Apixaban Matches Aspirin in Preventing Certain Strokes
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

United States , Jim Schnabel , Mitchell Elkind , Hooman Kamel , Department Of Neurology , American Heart Association , Presbyterian Weill Cornell Medical Center , Columbia University Vagelos College Of Physicians , Presbyterian Columbia University Irving Medical Center , Research Institute At Weill Cornell Medicine , Weill Cornell Medicine , Columbia University Vagelos College , Albert Moon Professor , Translational Neuroscience Unit , Feil Family Brain , Mind Research Institute , Weill Cornell Medical , Columbia University Irving Medical , American Heart , Atrial Cardiopathy , Weill Cornell ,